Dyne Therapeutics
(NASDAQ:DYN)
$24.73
1.035[4.37%]
At close: Apr 26
$24.73
0[0.00%]
After Hours: 4:20PM EDT

Dyne Therapeutics Stock (NASDAQ:DYN), Insider Trading Activity

Dyne Therapeutics: Insider buying and selling updated today.

Shares Outstanding
86.178M%
Insider Shares Owned
2.013M
Insider Percentage Owned
2.46%
Institutional Shares Held
28.495M
Institutional Percentage Held
33.1%
Filing Date
▲▼
Insider Names
▲▼
Insider Title
▲▼
Qty.
▲▼
Price
▲▼
Size ($)
▲▼
Type
▲▼
Δ Own
▲▼
Own
▲▼
Trade Dates
▲▼
SEC Filing
▲▼
Mar 13, 2024GATTI SUSANNA HIGHCHIEF OPERATING OFFICER-29.491K$26.59-$784.25KSELL-15.83%156.8KMar 08 - Mar 11View
Mar 13, 2024Jonathan McNeillCHIEF BUSINESS OFFICER-1.776K$15.82-$2.26MSELL-1.26%139.408KMar 08 - Mar 11View
Mar 12, 2024Wildon FarwellCHIEF MEDICAL OFFICER-2.615K$25.65-$67.08KSELL-1.71%150.56KMar 11 - Mar 12View
Mar 12, 2024Richard ScalzoSVP, HEAD FINANCE & ADMIN.-2.672K$15.87-$1.85MSELL-2.19%119.283KMar 08 - Mar 11View
Mar 12, 2024Joshua BrummCEO & PRESIDENT-16.387K$15.72-$8.84MSELL-2.96%537.998KMar 08 - Mar 11View
Mar 12, 2024Oxana BeskrovnayaCHIEF SCIENTIFIC OFFICER-2.081K$25.70-$53.48KSELL-1.35%152.352KMar 11View
Mar 11, 2024Joshua BrummCEO & PRESIDENT-9.086K$25.85-$234.87KSELL-1.61%554.385KMar 07View
Mar 11, 2024Oxana BeskrovnayaCHIEF SCIENTIFIC OFFICER-2.373K$25.85-$61.34KSELL-1.51%154.433KMar 07View
Mar 11, 2024GATTI SUSANNA HIGHCHIEF OPERATING OFFICER-1.591K$25.85-$41.13KSELL-0.85%186.291KMar 07View
Mar 11, 2024Wildon FarwellCHIEF MEDICAL OFFICER-9.921K$25.86-$256.58KSELL-6.08%153.175KMar 07View
Mar 11, 2024Jonathan McNeillCHIEF BUSINESS OFFICER-2.434K$25.85-$62.92KSELL-1.69%141.184KMar 07View
Mar 11, 2024Richard ScalzoSVP, HEAD FINANCE & ADMIN.-2.273K$25.85-$58.76KSELL-1.83%121.955KMar 07View
Mar 05, 2024Jason Rhodes-46.534K$30.05-$1.40MSELL-0.71%6.545479MMar 01View
Mar 05, 2024Atlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC10% OWNER-46.534K$30.05-$1.40MSELL-5.21%847.388KMar 01View
Mar 01, 2024Joshua BrummCEO & PRESIDENT0$17.25-$2.34MSELL-OPTIONS0.00%563.471KFeb 29 - Mar 01View
Mar 01, 2024Jonathan McNeillCHIEF BUSINESS OFFICER0$14.59-$791.04KSELL-OPTIONS0.00%143.618KFeb 29 - Mar 01View
Mar 01, 2024Richard ScalzoSVP, HEAD FINANCE & ADMIN.0$14.54-$344.17KSELL-OPTIONS0.00%124.228KFeb 29 - Mar 01View
Feb 28, 2024Jason Rhodes-807.838K$24.30-$19.63MSELL-48.31%864.487KFeb 26 - Feb 28View
Feb 28, 2024Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC10% OWNER-807.838K$24.30-$19.63MSELL-48.31%864.487KFeb 26 - Feb 28View

FAQ

Q

Is Insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch